Vimarsana
Biggest News Aggregation in the World

Page 14 - Mark Wilcox News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Wilcox. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Wilcox Today - Breaking & Trending Today

5 medical marijuana businesses in San Diego get OK to expand - Vimarsana News

5 medical marijuana businesses in San Diego get OK to expand

Businesses to expand their facilities can also begin selling recreational cannabis products.

Source: cbs8.com
5 Medical Marijuana Businesses Get OK to Expand, Sell Recreational Cannabis - Vimarsana News

5 Medical Marijuana Businesses Get OK to Expand, Sell Recreational Cannabis

SAN DIEGO—The San Diego County Board of Supervisors voted 4-1 to approve zoning changes that will allow five ...

5 Medical Marijuana Businesses Get OK to Sell Recreational Cannabis in Unincorporated San Diego County – NBC 7 San Diego - Vimarsana News

5 Medical Marijuana Businesses Get OK to Sell Recreational Cannabis in Unincorporated San Diego County – NBC 7 San Diego

The San Diego County Board of Supervisors Wednesday voted 4-1 to approve zoning changes that will allow five existing medical marijuana businesses to expand...

Selective Insurance Group, inc (SIGI) Q2 2021 Earnings Call Transcript - Vimarsana News

Selective Insurance Group, inc (SIGI) Q2 2021 Earnings Call Transcript

Operator Good day, everyone. Welcome to Selective Insurance Group's Second Quarter 2021 Earnings Call. At this time, for opening remarks and introductions, I would like to turn the call over to Senior Vice President, Investor Relations and Treasurer, Rohan Pai. Thank you. You may begin. John J. Marchioni -- President and Chief Executive Officer Thanks, and good morning, everyone. We're simulcasting this call on our website, selective.com, and the replay will be available until August 20, 2021. Our supplemental investor package, which provides GAAP reconciliations of any non-GAAP financial me...

Source: fool.com
Destiny Pharma PLC making significant strides towards phase III evaluation of potential breakthrough C.diff treatment - Vimarsana News

Destiny Pharma PLC making significant strides towards phase III evaluation of potential breakthrough C.diff treatment

CEO Neil Clark said: "We have made significant progress since closing the £10.4mln equity funding in December 2020 that enabled the NTCD-M3 acquisition.”